Drug combo safely decreases pancreatic cancer growth in mice

Drug combo safely decreases pancreatic cancer growth in mice

A new combination of treatments safely decreased growth of pancreatic cancer in mice by preventing cancer cells from scavenging for fuel, a new study finds. Led by researchers at NYU Grossman School of Medicine, its Department of Radiation Oncology, and the Perlmutter Cancer Center, the work builds on prior discoveries at NYU Langone that revealed … Read more

Novartis to present new oncology data at ESMO 2023

Novartis to present new oncology data at ESMO 2023

Key data from the Phase III PSMAfore trial has been selected for a Presidential session; PSMAfore is investigating PluvictoTM (INN: lutetium (177Lu) vipivotide tetraxetan) in the pre-chemotherapy setting for patients with PSMA-positive metastatic castration-resistant prostate cancer (mCRPC) New analysis of key subgroups of clinical interest from NATALEE reinforces the potential of Kisqali® (ribociclib) plus endocrine … Read more

New workflow could significantly reduce wait time for urgent palliative radiation therapy

New workflow could significantly reduce wait time for urgent palliative radiation therapy

Using previously taken diagnostic computed tomography (CT) scans in place of CT simulation scans to plan simple palliative radiation treatments can substantially reduce the time some people spend waiting for urgent treatment, improving the patient experience, a new study suggests. Patients who may benefit from this expedited process typically are experiencing pain or other debilitating … Read more

Teddi Mellencamp to start immunotherapy | Entertainment News

Teddi Mellencamp to start immunotherapy | Entertainment News

Teddi Mellencamp is to undergo immunotherapy to treat skin cancer. The ‘Real Housewives of Beverly Hills’ star revealed in October last year she had been diagnosed with stage 2 of the disease and last month, she told fans her latest biopsy had revealed another melanoma and now, in a new update, the 42-year-old star explained … Read more

Shorter course of radiation therapy just as effective for intermediate risk prostate cancer, study shows

Shorter course of radiation therapy just as effective for intermediate risk prostate cancer, study shows

People with intermediate risk, localized prostate cancer can be treated as effectively using fewer and higher doses of radiation therapy delivered over five treatment sessions as they can with lower doses delivered over several weeks, a new phase III randomized trial suggests. The findings, which are the latest from a series of studies investigating the … Read more

Len Goodman’s cause of death revealed | Entertainment News

Len Goodman’s cause of death revealed | Entertainment News

Len Goodman’s cause of death has been revealed five months after his death. The ‘Dancing with the Stars’ and ‘Strictly Come Dancing’ judge’s prostate cancer had spread to his bones with his death certificate, obtained by The Daily Express, listing the cause as metastatic prostate cancer. The TV legend was first diagnosed with prostate cancer … Read more

New AI model improves accuracy of tumor removal in breast cancer surgery

New AI model improves accuracy of tumor removal in breast cancer surgery

Artificial intelligence (AI) and machine learning tools have received a lot of attention recently, with the majority of discussions focusing on proper use. However, this technology has a wide range of practical applications, from predicting natural disasters to addressing racial inequalities and now, assisting in cancer surgery. A new clinical and research partnership between the … Read more

Study finds majority of TikTok gynecologic cancer advice to be misleading or inaccurate

Study finds majority of TikTok gynecologic cancer advice to be misleading or inaccurate

Millions of women are turning to the social media platform TikTok for health advice related to gynecologic cancers, but the majority of that information is misleading or dramatically inaccurate, according to a new study published by The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute … Read more

New tool may help identify inflammatory breast cancer quicker and at earlier stages

New tool may help identify inflammatory breast cancer quicker and at earlier stages

A new diagnostic scoring system, developed by renowned breast cancer experts, is now available as an easy-to-use online tool through Susan G. Komen®, the world’s leading breast cancer organization. This tool will help health care providers recognize and effectively diagnose a rare and aggressive breast cancer, inflammatory breast cancer. The new Inflammatory Breast Cancer (IBC) … Read more

New consensus statement provides guidance for use of 177Lu-PSMA radionuclide therapy in mCRPC patients

New consensus statement provides guidance for use of 177Lu-PSMA radionuclide therapy in mCRPC patients

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has issued a new consensus statement to provide standardized guidance for the selection and management of metastatic castrate-resistant prostate cancer (mCRPC) patients being treated with 177Lu-PSMA radionuclide therapy. The statement, published in the July issue of The Journal of Nuclear Medicine, also reviews current clinical struggles … Read more